Sökning: "Ingrid Øra"

Hittade 3 avhandlingar innehållade orden Ingrid Øra.

  1. 1. Approaches to Treatment of Children with Advanced Neuroblastoma

    Författare :Ingrid Øra; Lund Pediatrik; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Pediatrics; drug resistance; hypoxia; apoptosis; arsenic trioxide; treatment; diagnosis; neuroblastoma; sympathetic nervous system; Pediatri; Cytology; oncology; cancerology; Cytologi; onkologi; cancer;

    Sammanfattning : Children with advanced neuroblastoma are at high risk for relapse of multidrug resistant disease, despite initial response to intensive multimodality treatment. Neuroblastomas have similarities with immature neuroblasts seen during embryonic development of the sympathetic nervous system (the origin of these tumors). LÄS MER

  3. 2. Hodgkin Lymphoma in children, adolescents and young adults

    Författare :Annika Englund; Gustaf Ljungman; Gunilla Enblad; Rose-Marie Amini; Daniel Molin; Ingrid Øra; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Hodgkin; pediatric; adolescent; young adults; microenvironment; eosinophils; mast cells; macrophages; Sweden; late adverse effects; Pediatrik; Pediatrics; Medicinsk vetenskap; Medical Science; Oncology; Onkologi;

    Sammanfattning : Hodgkin lymphoma (HL) is a heterogeneous condition varying from engaging one single lymph node site to a widespread condition. The prognosis with contemporary treatment is excellent for the vast majority. However, the treatment might cause severe late adverse effects in a proportion of the affected individuals. LÄS MER

  4. 3. On the Diagnostics of Neuroblastoma : Clinical and Experimental Studies

    Författare :Kleopatra Georgantzi; Åke Jakobson; Ingrid Øra; Uppsala universitet; []
    Nyckelord :Neuroendocrine; Immunohistochemistry; Urinary Catecholamine Metabolites; Markers; Outcome;

    Sammanfattning : Neuroblastoma (NB) is one of the most common childhood cancers. Patients with low stage tumor have high survival rate, while those with advanced stage and/or unfavorable molecular biology have poor prognosis. LÄS MER